Skip to main content
Gut logoLink to Gut
. 1970 Feb;11(2):171–175. doi: 10.1136/gut.11.2.171

Clinical study of Duogastrone in the treatment of duodenal ulcers

B O Amure
PMCID: PMC1411344  PMID: 4909818

Abstract

This study confirms the preliminary reports that Duogastrone effectively controls the symptoms of duodenal ulceration and appears to hasten healing. In a double-blind trial, 14 patients with active duodenal ulcers were treated with Duogastrone capsules, one four times daily, half-an-hour before meals, while a comparable control group of 14 patients was treated similarly with a placebo containing magnesium trisilicate. Treatment continued for 12 weeks with clinical assessments fortnightly and a radiological assessment at the start and at the end of treatment.

Only one of the 14 patients receiving Duogastrone did not respond. The remaining 13 showed marked clinical improvement with complete relief of pain and ceased to require supplementary antacids. Radiological evidence of healing or marked improvement was seen in eight of the 14 patients.

None of the patients in the control group showed any marked improvement either of pain or tenderness and no changes were detectable by radiology. Patients in this group showed no reduction in their demand for supplementary antacids to relieve symptoms. No significant side effects were encountered.

It is concluded that Duogastrone accelerates the healing of duodenal ulcer in ambulant patients and affords a much greater and more rapid relief of symptoms than does magnesium trisilicate.

Full text

PDF
172

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craig O., Hunt T., Kimerling J. J., Parke D. V. Carbenoxolone in the treatment of duodenal ulcer. Practitioner. 1967 Jul;199(189):109–111. [PubMed] [Google Scholar]
  2. Jones F. A. Carbenoxolone. Practitioner. 1965 Nov;195(169):698–700. [PubMed] [Google Scholar]
  3. Montgomery R. D., Lawrence I. H., Manton D. J., Mendl K., Rowe P. A controlled trial of carbenoxolone sodium capsules in the treatment of duodenal ulcer. Gut. 1968 Dec;9(6):704–706. doi: 10.1136/gut.9.6.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Montgomery R. D., Mehta S. C., Lawrence I. H. Carbenoxolone in the long-term management of gastric ulcer. Practitioner. 1969 Mar;202(209):398–404. [PubMed] [Google Scholar]
  5. Samuel O. W. Periadenitis mucosa necrotica recurrens treated with topical carbenoxolone gel. Practitioner. 1967 Aug;199(190):220–222. [PubMed] [Google Scholar]
  6. Simpson P. M. Work in an oral surgery unit. Dent Health (London) 1967 Jul-Sep;6(3):47–50. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES